Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Return on Capital Employed (2016 - 2026)

Avanos Medical's Return on Capital Employed history spans 12 years, with the latest figure at 6.8% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 2517.0% to 6.8% in Q4 2025 year-over-year; TTM through Dec 2025 was 6.8%, a 2517.0% increase, with the full-year FY2025 number at 6.49%, up 2502.0% from a year prior.
  • Return on Capital Employed hit 6.8% in Q4 2025 for Avanos Medical, up from 53.3% in the prior quarter.
  • Over the last five years, Return on Capital Employed for AVNS hit a ceiling of 3.03% in Q4 2022 and a floor of 53.3% in Q3 2025.
  • Historically, Return on Capital Employed has averaged 9.26% across 5 years, with a median of 0.59% in 2022.
  • The widest YoY moves for Return on Capital Employed: up 2517bps in 2025, down -5562bps in 2025.
  • Tracing AVNS's Return on Capital Employed over 5 years: stood at 2.65% in 2021, then surged by 214bps to 3.03% in 2022, then plummeted by -91bps to 0.28% in 2023, then plummeted by -11320bps to 31.97% in 2024, then surged by 79bps to 6.8% in 2025.
  • Business Quant data shows Return on Capital Employed for AVNS at 6.8% in Q4 2025, 53.3% in Q3 2025, and 50.14% in Q2 2025.